Median Fib-4 for these patients was also higher (1.82 vs 1.44), although this did not reach statistical significance ( P = 0.056).
← all excerpts
Using Panel Management to Identify Adult Patients With High-Risk Metabolic Dysfunction-Associated Steatotic Liver Disease/Metabolic Dysfunction-Associated Steatohepatitis Fibrosis in a Primary Care Clinic: A Pilot Study.
1
0.0560
0.0560